Abstract:OBJECTIVES:Small cell lung cancer (SCLC) is notorious for aggressive malignancy without effective treatment, and most patients eventually develop tumor progression with a poor prognosis. There is an urgent need for discovering novel antitumor agents or therapeutic strategies for SCLC.MATERIALS AND METHODS:We performed a screening method based on CCK-8 assay to screen 640 natural compounds for SCLC. The effects of Sanguinarine chloride on SCLC cell proliferation, colony formation, cell cycle, apoptosis, migration and invasion were determined. RNA-seq and bioinformatics analysis was performed to investigate the anti-SCLC mechanism of Sanguinarine chloride. Publicly available datasets and samples were analyzed to investigate the expression level of CDKN1A and its clinical significance. Loss of functional cancer cell models were constructed by shRNA-mediated silencing. Quantitative RT-PCR and Western blot were used to measure gene and protein expression. Immunohistochemistry staining was performed to detect the expression of CDKN1A, Ki67, and Cleaved caspase 3 in xenograft tissues.RESULTS:We identified Sanguinarine chloride as a potential inhibitor of SCLC, which inhibited cell proliferation, colony formation, cell cycle, cell migration and invasion, and promoted apoptosis of SCLC cells. Sanguinarine chloride played an important role in anti-SCLC by upregulating the expression of CDKN1A. Furthermore, Sanguinarine chloride in combination with panobinostat, or THZ1, or gemcitabine, or (+)-JQ-1 increased the anti-SCLC effect compared with either agent alone treatment.CONCLUSIONS:Our findings identified Sanguinarine chloride as a potential inhibitor of SCLC by upregulating the expression of CDKN1A. Sanguinarine chloride in combination with chemotherapy compounds exhibited strong synergism anti-SCLC properties, which could be further clinically explored for the treatment of SCLC.

The Synthesis and Biological Evaluation of Sanguinarine Derivatives As Anti-Non-small Cell Lung Cancer Agents

A Novel Myricetin Derivative with Anti-cancer Properties Induces Cell Cycle Arrest and Apoptosis in A549 Cells.

Synthesis of Novel Spin-Labeled Derivatives of 5-FU As Potential Antineoplastic Agents

Design, Synthesis, and Biological Evaluation of Novel Apigenin Derivatives as Potential Antitumor Agents

Re-engineering and synthesis of cytotoxic 2,3:7,8-di(alkylenedioxy)-extended analogs of quaternary sanguinarine chloride

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

New Safrole Oxide Derivatives: Synthesis and in Vitro Antiproliferative Activities on A549 Human Lung Cancer Cells

Sanguinarine Represses the Growth and Metastasis of Non-small Cell Lung Cancer by Facilitating Ferroptosis

Synthesis and Evaluation of Novel Isoxazolyl Chalcones As Potential Anticancer Agents.

Synthesis of NSAIDs–Se Derivatives As Potent Anticancer Agents

Natural Compound Library Screening Identifies Sanguinarine Chloride for the Treatment of SCLC by Upregulating CDKN1A.

Cytostatic Activity of Sanguinarine and a Cyanide Derivative in Human Erythroleukemia Cells Is Mediated by Suppression of c-MET/MAPK Signaling

Synthesis and Biological Evaluation of Nitrate Derivatives of Thiocolchicine as Potential Anticancer Drugs

Synthesis and biological evaluation of novel penindolone derivatives as potential antiproliferative agents against SCLC in vitro

Synthesis of Flavonols and Assessment of Their Biological Activity as Anticancer Agents

Sanguinarine Attenuates Lung Cancer Progression via Oxidative Stress-induced Cell Apoptosis

Synthesis and Cytotoxic Evaluation of Novel C-10 Nitrate Derivatives of Colchicine

Synthesis and Biological Evaluation of Organoselenium (Nsaids-Secn and SeCF3) Derivatives As Potential Anticancer Agents.

Design, synthesis and anti-NSCLC activity of hybrids of anilinopyrimidines and diazeniumdiolates

Syntheses and Anti-Cancer Activities of Derivatives of Tetrandrine and Fangchinoline

Synthesis And Biological Evaluation Of Novel Withangulatin A Derivatives As Potential Anticancer Agents